A topical combination preparation primarily used as a local anesthetic, antiseptic, and counter-irritant for the symptomatic relief of ear pain, particularly in conditions like otitis externa. Benzocaine provides surface anesthesia, Chlorbutol acts as an antiseptic and mild local anesthetic, Paradichlorobenzene serves as an insecticidal agent, and Turpentine Oil acts as a counter-irritant and rubefacient. This combination is formulated as ear drops and is intended for short-term, symptomatic management.
Adult: Instill 2-4 drops into the affected ear 3 to 4 times daily, or as directed by the physician. Do not exceed 4 times daily.
Note: 1. Warm the bottle in hands for 1-2 minutes. 2. Lie on side with affected ear upward. 3. Gently pull the outer ear backward and upward (adults) or backward and downward (children) to straighten the ear canal. 4. Instill the prescribed number of drops. 5. Remain in position for 5 minutes. 6. Place a cotton plug loosely in the ear opening. Do not insert dropper into ear canal. For bilateral otitis, repeat procedure for the other ear.
The combination exerts its effects through multiple mechanisms: 1) Benzocaine blocks sodium channels on neuronal membranes, inhibiting the initiation and conduction of nerve impulses, leading to reversible local anesthesia. 2) Chlorbutol (Chlorobutanol) possesses antibacterial and antifungal properties, acting as a preservative and mild local anesthetic. 3) Paradichlorobenzene sublimes and acts as an insecticidal agent, historically intended to kill mites or insects in the ear canal. 4) Turpentine Oil acts as a counter-irritant, causing mild irritation and hyperemia of the skin, which may provide a distracting sensation from deeper pain (gate control theory) and improve local blood flow.
Pregnancy: Category C (US FDA). Animal reproduction studies not conducted. Use only if clearly needed and potential benefit justifies potential risk to the fetus. Topical application to ear canal is unlikely to result in significant systemic exposure.
Driving: The medication itself is unlikely to affect driving. However, underlying ear condition (vertigo, pain) or rarely, dizziness from cold drops, may impair ability. Patients should be cautious.
| Sulfonamides (e.g., Cotrimoxazole) | Benzocaine metabolizes to PABA, which may antagonize the antibacterial effect of sulfonamides. | Moderate |
| Other topical otic preparations (e.g., antibiotic-steroid drops) | Physical or chemical incompatibility. May dilute or inactivate each other. A time gap of at least 30 minutes is recommended. | Moderate |
| Systemic drugs metabolized by CYP450 (e.g., Phenytoin, Warfarin) | Theoretical interaction if significant systemic absorption of Turpentine Oil occurs, as it induces CYP450 enzymes. Clinically significant interaction is unlikely with otic use. | Low |